Harriet joined Orbit in 2024 as part of the graduate scheme and is now looking after the Asset Management, Fintech and service provider clients and partnerships alongside Terri Morgan, leading clients through their Responsible Investment Services & strategies and AI integration within ESG.

Harriet's previous experience from working as a research scientist at a Biotech startup researching novel oncolytic immunotherapies, has translated over to driving key research themes using the Orbit Investment research platform for Investment analysists in the Sustainable Investment and ESG industry.

Harriet holds an BSc (Hons) & DiiP Pharmacology & Drug Development.